Alexander Lourdes Samy, Zahra Fazli Khalaf, & Wah-Yun Low
1
Aliku, T. et al.
1
Alipanah N, Jarlsberg L et al.
1
Allach, Y.
1
Alves, C.
1
American Research Foundation,
1
Amini, M.
1
Ana Carvajal, José Félix Oletta López, Alejandro Rísquez
1
Anaya-Covarrubias, J.Y.
1
and C. Sabine
1
Annim, Samuel Kobina, Kofi Awusabo-Asare, and Joshua Amo-Adjei
1
Arjadi , R.
1
Ashleigh Tuite
1
Aung Zayar Paing
1
Aye Kyawt Paing et al.
1
Åsa Hammar and Guro Årdal
1
B. Ezenwa
1
Banerjee, A.
1
Bapoutou, B.
1
Barnes, H.
1
Bazargani, Y.T.
1
Bălă, G.P.
1
Begum, T. S. M.
1
Bendavid E. et al.
1
Berry, P.
1
Betrò, S.
1
Bham A., J. Bhiman, F. Bongweni et al.
1
Bham, A.
1
Bio Med Central
1
BMC Cardiovascular Disorders
1
BMC Infectious Diseases
1
BMJ Global Health
1
BMJ Journals
1
BMJ Open
1
Bo Peng , Rowland W. Pettit, and Christopher I. Amos
1
Bo Wen, Rongbin Xu, Yao Wu, Micheline de Sousa Zanotti Stagliorio Coelho et al.
1
Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (2005). WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa
1
Bonita, R.
1
Bortone, B.
1
Bozorgmehr, K.
1
Braae, U.
1
Brandon A. Kohrt,Laura Asher, Anvita Bhardwaj, et al.
1
Breathe, part of the European Respiratory Society (ERS)
1
Breitner-Busch, S.
1
Budreviciute, A.
1
Bush, A.
1
C. C. Johnson
1
C. Contini, M. Maritari, M. die Nuzzo, et al.
1
C. Giannou, M. Baldan and A. Molde
1
C. Hoffmann, et al.
1
C. Hughes
1
C. K. Mbuba
1
C. Kennedy
1
C. R. Newton
1
C. Wilcox, L. Lebreton et al.
1
Camp, R. and C. Hoffmann
1
Carbonell, C.
1
Cardiovascular Diagnosis and Therapy
1
Cawthrope, D.
1
Center for Disease Control
1
Center for Global Development
1
Centers for Disease Control and Prevention
1
Centers for Disease Control and Prevention (CDC)
1
Centers for Disease Control and Prevention, National Center for HIV
1
Centers for Diseases Control and Prevention
1
Central Research Institute of Epidemiology of Rospotrebnadzor
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Centre for Respiratory Diseases and Meningitis and Outbreak Response
1
Chakaya, J.
1
Chambliss, S. E.
1
Charles B. Nemeroff
1
Chas J., Hema A., Slama L. et. al.
1
Chou-Zen Giam
1
Chowdhary, N.
1
Chowell and Nishiura
1
Christa L Fischer Walker, Igor Rudan, Li Liu, Harish Nair, et al.
1
Chu, D.K.
1
Ciais, P.
1
Cianconi, P.
1
Circulation
1
CMAM Forum
1
Cochrane
1
Cogent Medicine
1
Cole CP, James PB, Kargbo AT
1
College of American Pathologists
1
Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL)
1
Consorcio Latinoamericano de Anticoncepción de Emergencia (CLAE), Naciones Unidas, et al.
1
Convention on Biological Diversity
1
Cosgrave, J.
1
COVID-19 Mental Disorders Collaborators
1
Cupertino, M. C.
1
D. Antognini, A. Combes, et al.
1
D. Daniels
1
D. Daniels, C. Smyth, et al.
1
D. Daniels, et al.
1
D. Gomez-Pastrana
1
D. Luo
1
D. O’Mahony
1
Dai, W., Kaminga, A.C., Tan, H., Wang, J., Lai, Z., Wu, X., Xiong, Y., Deng, J. & Liu, A.
Department of Health Research Ministry of Health & Family Welfare
1
Dèdonougbo Houenassi, M.
1
Dhan Bahadur Shrestha, Pravash Budhathoki, Bipana Gurung et al.
1
Dheda, K.
1
Diabetes & Metabolism Journal
1
Diabetes Internacional, Universidad Central de Venezuela
1
Diouf A., T. J. Youbong, F. L. Dieye et. al.
1
DIRECCIÓN GENERAL DE SALUD PÚBLICA, CALIDAD E INNOVACIÓN
1
Directorate General of Health Services Ministry of Health & Family Welfare Government of the People’s Republic of Bangladesh
1
Doyle, M.P.
1
Dr. Luis Távara Orozco
1
Dr. T. Waite
1
Duarsa, G.W.K., D.M. Soebadi, A. Taher, et al.,
1
E. L. Petroski
1
E.A Akl, S. Duda, et al.
1
E.Schuler
1
Echazarreta, A.
1
Eckstein, D.
1
El Gobierno des Todos, Ecuador
1
Elsevier Ltd
1
END TBc1
1
Environment and Society Programme
1
Environment International
1
Environmental Science and Pollution Research
1
Epidemiologisches Bulletin
1
Erwinanto, A. Santoso, J. N. E. Putranto, et al.,
1
Espira, L. M.
1
Etienne V Langlois, Andrew Mc Kenzie, Helen Schneider & Jeffrey W Mecaskey
1
EuroHealth Observer
1
European Centre for Disease Prevention and Control ECDC
1
European Monitoring Centre for Drugs and Drug Addiction
1
European Observatory on Health Systems and Policies Eurostation
1
European Respiratory Journal, part of the European Respiratory Society (ERS)
1
European Society of Clinical Microbiology and Infectious Diseases EUCAST
1
Eurosurveillance
1
Evangelina IN, Inês T, Miguelhete L et al
1
Ewig S.
1
EXPERT REVIEW OF ANTICANCER THERAPY2020, VOL. 20, NO. 4, 271–278
1
Eyring V., Gillett N. P., et al.
1
F. Biadglegne, U. Sack, A. C. Rodloff
1
F. Bozzani et al.
1
F. Zermoglio
1
Fajolu, I.
1
Ferrante, G.
1
Ferres M., Potin M.
1
Field Epidemiology Services (Public Health England)
1
Fiona Charlson, Suhailah Ali, Jura Augustinavicius et al.
1
Fitzgerald, D.A. et al.
1
Fitzgerald, F.
1
Florian Lederbogen, Leila Haddad, Andreas Meyer-Lindenberg
1
Flying Publisher, Boehringer Ingelheim
1
Food and Agriculture Organization (FAO)
1
Frank, A.
1
Frase N. S.
1
Freedman, B.
1
Friedman, J.F. et al.
1
Frontiers in Cardiovascular Medicine
1
Frontiers in Pediatrics
1
G, Zambrano, E Salgato, F. M. Moyano et al.
1
G. B Kulkarni
1
G. Bishwajit, C. Zhaohui, H. Zhifei
1
G. Gururaj
1
G. H. Loneragan, H. M. Scott et al.
1
G. N. Rao
1
Gabrys, J.
1
GBD 2019 Blindness and Vision Impairment Collaborator
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
GBD2019 Dementia Forecasting Coolaborators
1
Germanwatch e.V.
1
Gil, A.
1
Girum T., Wasie A. and Worku A.
1
Gleeson, T.
1
Glenn, B. E.
1
Global Mental Health
1
Goh, N. S. L.
1
Greenhalgh, T.
1
Greinacher, A., et al.
1
Grimshaw, J. M.
1
Gruetzmacher, K.
1
Gulani, A. & Sachdev, H.P.S
1
Gulev S. K., Thorne P. W. et al.
1
H. Kuper and K. Blanchett , et al.
1
H. Thirumurthy, E. Omanga, B. Obonyo et al.
1
H.L. Nguyen
1
Haefele-Abah, C.
1
Halaharvi, H.
1
Haute Conseil de la Santé Publique
1
Health Cluster
1
Health Service and Population Research Department,Institute of Psychiatry, King's College London
1
Healthcare Journal
1
Hellen Gelband,Jha Prabhat, Rengaswamy Sankaranarayanan et al.
1
Hepatology Society of the Philippines
1
Hepatology Society of the Philippines (HSP)
1
Hiller, R.M., Meiser-Stedman, R., Fearon, P., Lobo, S., McKinnon, A., Fraser, A. & Halligan, S.L.
1
Hindricks, G.
1
Hitzeroth, J.
1
HIV i-Base
1
HIV i-BASE/TREATMENT ACTION GROUP
1
Ho T., Cusack R.P., Chaudhary N. et al.
1
Hogg Foundation for Mental Health
1
Hong‑Mei Luo
1
Hoviyeh Afnan-Holmes, Moke Magoma, Theopista John, et al.
1
Hoy, R.
1
Hsia Y., B. R Lee, A. Versporten, et al
1
Hua Yu
1
Huffman, M. et al.
1
I. J. C. Schneider
1
I. Mokrousov, (St. Petersburg Pasteur Institute)
1
iMMAP
1
Imperial College COVID-19 Response Team
1
Indian Consensus of Medical Research
1
Indian Council of Medical Research
1
Indian Council of Medical Research (ICMR)
1
Institutional Treatment,Human Rights and CareAssessment (ITHACA)
1
Instituto Nacional del Cancer and Ministerio de Salud, Argentina
1
INTECH
1
International Committee of the Red Cross ICRC
1
International Diabetes Federation
1
International Diabetes Federation IDF
1
International I nitiativ e for Impact E valuation (3ie)
1
International Journal of Behavioral Science
1
International Journal of Infectious Diseases
1
International Plant Nutrition Institute, International Fertilizer Industry Association
1
International Union Against Tuberculosis and Lung Disease, World Health Organization
1
IOP Science
1
IPCC
1
IPNI, IFA
1
Iris (Institutional Repository)
1
Istituto Superiore di Sanità (ISS)
1
J Family Med Prim Care
1
J. Bhiman, F. Bongweni et al.
1
J. Wolf
1
J. Wolf, C. Corvalán, et al.
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
JAMIA Open
1
Janiri, L.
1
Jésuites d'Afrique de l'Ouest
1
John Beard, Alana Officer, Andrew Cassels et al.
1
Jose Bertolote, José Miguel Caldas de Almeida, Thomas Bornemann et al.
1
José Bertolote, Michelle Funk, Vladimir Poznyak et al.
1
Journal of AIDS & Clinical Research
1
Journal of Allergy and Clinical Immunology: Global
1
journal of Global health
1
Journal of Health Monitoring
1
Journal of the American College of Cardiology
1
Julián-Jiménez, A.
1
K. Tolksdorf
1
K. vinh quoc Luong, L. T. H. Nquyen
1
K.L.Ebi
1
Kalafs.S.
1
Kang Yiu Lai, Wing Yiu George Ng and Fan Fanny Cheng
1
Karagiannidis, C.
1
Kengne, A.P. et al.
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
Khdr Sabir, D. et al.
1
Khuluza, F.
1
Kim, A.
1
Kirakoya-Samadoulougou F., K. Jean, M. Maheu-Giroux
1
Kirenga, B.J.
1
Kishimoto T., Robenzadeh A, Leucht C, et al.
1
Klug, E. et al.
1
Kohler, S.
1
Kopittke, P.M.
1
Korenromp E.
1
Kuate, L.M. et al.
1
Kumar Roy., S. and S. Bhattacharjee
1
Kunda J., Gosling S., Foody G. et al.
1
L. Alfieri, M. Flörke et al.
1
L. Cai
1
L. R. Augustemak de Lima
1
L. Zhou
1
L.Houétondji Codjo, D. Dokoui, S, et al.
1
La Grutta, S.
1
Ladnaya, N.
1
Larson, M. C.
1
Larson, P. S.
1
Lee J. Y., Marotzke J., et al.
1
Lee, V.
1
Lenney, W.
1
Leong, T. L.
1
Leufkens, H.G.M. et al.
1
Lewis, C. Jr., Akinyi, M., DeWitte, S. et al.
1
Limeira, C.
1
Linju Maria, J.
1
Lockwod DN.
1
Lode, H.
1
López-Bernús, A.
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. F. Biudes
1
M. G. Whitfield, H. M. Soeters, R. M. Warren, et al.
1
M. Janier, V. Hegyi, N. Dupin et al
1
M. Langer
1
M. Lefebvre
1
M. Mayan
1
M. Mntonintshi
1
M. Nebuloni
1
M. Roser, P. Geldsetzer, T. Bärnighausen
1
M. Vitoriaa
1
M.J. Nieuwenhuijsen, M. Gascon
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Mailloux, N.A. et al.
1
Makanjuola, A. et al.
1
Makwe, C.
1
Manas R. , Behera R., Satpathy S.K.
1
Margaret Grigg , Michelle Funk, Natalie Drew et al.
1
Maria Faurholt-Jepsen, Michael Bauer and Lars Vedel Kessing
1
Martínez-Austria Polioptro,F and Bandala E. R
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Mathieu Maheu-Giroux, Lawrence Joseph, Patrick Belisle and others
1
Mburu, Gitau
1
McKee, M.
1
MDPI Journal of Clinical Medicine
1
Medicine
1
Mensah, G.A.
1
Mercado, S.
1
Mercedes M. Maicán V., Ángel Granado, Jesús Cedeño, et al.
1
Médecins sans Frontières MSF
1
mhGAP
1
MI. Troya,B. Bartlam, and C. A. Chew-Graham
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Michelle Funk, José Miguel Caldas de Almeida, Natalie Drew et al.
1
Military Medical Research
1
Minh D Pham
1
Ministerio da Saude, Brasilia
1
Ministerio de Salud Chile
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministry of Health, Kenya
1
Minja, N.W.
1
Modi, D., N. Dholakia, R. Gopalan, et al.
1
Mohamed, S.F.
1
Morse, J.M.
1
Moudatsou, M.
1
Mpe, M.
1
MSMGF
1
Mukund Uplekar, Diana Weil, Hannah Monica Dias et al.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
Muntean Al., Popa M.
1
Mücke, H.
1
Mwangi M., Mutua1 M.K., et al.
1
Mya, Kyaw Swa, Aung Tin Kyaw, and Thandar Tun
1
N. Forda
1
N. G. Kiobi, S. N. Nebere, J. K. Karanja
1
N. J. Sagala, S. Sofyani, Supriatmo
1
N. L. Soh
1
N. L. Soh
1
N. Petrosillo
1
Nakagaayi, D.
1
Nalbandian, A.
1
National AIDS Commission MAlawi
1
National Department of Health, South Africa
1
National Library of Medicine
1
Nauta, M. H.
1
NCBI (National Center for Biotechnology Information)
1
NdOH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Neuron Review
1
Nganou-Gnindjio, C.N.
1
Niilo Mäki Institute
1
Nomura S. et al.
1
Noubiap, J.J.
1
Ntusi, N.A.B.
1
Nwe Ni Myint et al.
1
O'Sullivan, B.
1
Official Journal of the Asian Pacific Society of Respirology
1
OPAS, OMS
1
OPS
1
Organisation de la Santé Mondiale
1
Organisation mondiale de la Santé
1
Organización Mundial de la Salud (OMS)
1
Organización Mundial de Saude and OPAS
1
Organización Panamericana de la Salud OPS
1
Organização Mundial da Saúde (Américas)
1
Organização Pan-Americana da Saúde
1
OVID-19 Excess Mortality Collaborators
1
P. M. Enright, J. Shumake-Guillemot et al.
1
Paediatrica Indonesiana
1
PAHO (Pan American Health Organization
1
Pan American Health Organization (PAHO)
1
Pan American Health Organization PAHO, World Health Organization WHO
Die WHO hat mit Hilfe der Delphi-Methode eine klinische Falldefinition für das Post-COVID-19-Syndrom entwickelt, die 12 Domänen umfasst und in allen Bereichen verwendet werden kann. Diese erste Version wurde von Patienten, Forschern und anderen Personen aus allen WHO-Regionen entwickelt, wobei dav...on ausgegangen wird, dass sich die Definition ändern kann, wenn sich neue Erkenntnisse ergeben und sich unser Verständnis der Folgen von COVID-19 weiterentwickelt.
Die Post-COVID-19-Erkrankung tritt bei Personen mit einer wahrscheinlichen oder bestätigten SARS-CoV-2-Infektion in der Anamnese auf, in der Regel drei Monate nach dem Auftreten von COVID-19 mit Symptomen, die mindestens zwei Monate anhalten und nicht durch eine andere Diagnose erklärt werden können. Zu den häufigen Symptomen gehören Müdigkeit, Kurzatmigkeit, kognitive Störungen, aber auch andere Symptome, die sich im Allgemeinen auf das tägliche Leben auswirken. Die Symptome können nach der anfänglichen Genesung von einer akuten COVID-19-Episode neu auftreten oder nach der ersten Erkrankung fortbestehen. Die Symptome können auch schwanken oder im Laufe der Zeit wieder auftreten.more
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs et d'autres personnes, représentant... toutes les Régions de l'OMS, étant entendu que la définition peut changer à mesure que de nouvelles preuves apparaissent et que notre compréhension des conséquences de la COVID-19 continue d'évoluer.
L'état post COVID-19 survient chez les personnes ayant des antécédents d'infection probable ou confirmée par le CoV-2 du SRAS, généralement 3 mois après l'apparition de symptômes qui durent au moins 2 mois et ne peuvent être expliqués par un autre diagnostic. Les symptômes courants comprennent la fatigue, l'essoufflement, le dysfonctionnement cognitif mais aussi d'autres et ont généralement un impact sur le fonctionnement quotidien. Les symptômes peuvent être d'apparition récente après le rétablissement initial d'un épisode aigu de COVID-19 ou persister depuis la maladie initiale. Les symptômes peuvent également fluctuer ou rechuter au fil du temps.more
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...al dose of all WHO approved vaccines “since these individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe COVID-19 disease.”
People aged 60 and older who received the Sinovac and Sinopharm vaccines should get a third dose too, the experts added, though use of other vaccines may also be considered depending on supply and access.
“When implementing this recommendation, countries should initially aim at maximizing 2-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups”, they said.
SAGE has also reviewed a vaccine developed by Indian company Bharat Biotech and will issue a policy recommendation after WHO greenlights it for emergency use.more
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...method, nucleic acid amplification tests (NAATs). This interim guidance offers recommendations on the priority uses of antigen-detecting rapid diagnostic tests (Ag-RDTs) in specific populations and settings, including (i) for primary case detection in symptomatic individuals suspected to be infected and asymptomatic individuals at high risk of COVID-19, (ii) for contact tracing, (iii) during outbreak investigations and (iv) to monitor trends of disease incidence in communities. Ag-RDTs meeting minimum performance requirements can be used outside of clinical and laboratory settings, including in communities, by trained operators in accordance with instructions. The guidance additionally provides recommendations on implementation, product selection and storage.more
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...y change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others and generally have an impact on everyday functioning. Symptoms may be new onset following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.more
The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising... poverty contributed to girls’ increased risk of female genital mutilation (FGM). School closures limited the monitoring and reporting of cases of FGM. Rising household monetary poverty may have contributed to families adopting negative coping mechanisms, including having girls undergo FGM as a precursor to marriage to reduce household costs. A report from the United Nations Population Fund (UNFPA) estimates 2 million additional cases of FGM by 2030 due to the pandemic.more
La détection directe des protéines virales du SRAS-CoV-2 (antigènes) dans les écouvillons nasaux et autres sécrétions respiratoires à l'aide de tests immunologiques à flux latéral (également appelés tests de diagnostic rapide, TDR) offre une méthode plus rapide et moins coûteuse pour te...ster le SRAS-CoV-2 que la méthode de référence, les tests d'amplification des acides nucléiques (TAAN). Ces lignes directrices provisoires offrent des recommandations sur les utilisations prioritaires des tests de diagnostic rapide à détection d'antigène (TDR-Ag) dans des populations et des contextes spécifiques, notamment (i) pour la détection primaire des cas chez les personnes symptomatiques suspectées d'être infectées et les personnes asymptomatiques à haut risque de COVID-19, (ii) pour la recherche des contacts, (iii) pendant les enquêtes sur les épidémies et (iv) pour surveiller les tendances de l'incidence de la maladie dans les communautés. Les TDR-AG répondant aux exigences minimales de performance peuvent être utilisés en dehors des milieux cliniques et des laboratoires, y compris dans les communautés, par des opérateurs formés conformément aux instructions. Le guide fournit en outre des recommandations sur la mise en œuvre, la sélection des produits et le stockagemore
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...ests, ce qui a entraîné un nombre moins important de cas identifiés de COVID-19 chez les enfants. Si les enfants présentant des symptômes légers ou inexistants transmettent la maladie, ils peuvent agir comme des vecteurs de transmission au sein de leur communauté. Il est essentiel de comprendre les symptômes, l'infectivité et les modes de transmission du SRAS-CoV-2 chez les enfants et les adolescents pour développer, adapter et améliorer les mesures de contrôle du COVID-19 à tous les âges. Ce document est un résumé des connaissances actuelles concernant l'acquisition et la transmission de l'infection par le SRAS-CoV-2 et les symptômes de la maladie COVID-19 chez les enfants et les adolescents. Il vise à éclairer les décisions, en fonction des contextes locaux, sur la meilleure façon de maintenir ouvertes les écoles, les jardins d'enfants et les crèches et sur les conseils à appliquer en matière de mixité intergénérationnelle.more
The coronavirus disease 2019 (COVID-19) pandemic has created a global and gendered crisis that is compounding existing inequalities and disproportionately affecting girls and women. Emerging evidence from the COVID-19 crisis in 2020 shows school closures, disruptions in essential services and rising... poverty contributed to girls’ increased risk of female genital mutilation (FGM). School closures limited the monitoring and reporting of cases of FGM. Rising household monetary poverty may have contributed to families adopting negative coping mechanisms, including having girls undergo FGM as a precursor to marriage to reduce household costs. A report from the United Nations Population Fund (UNFPA) estimates 2 million additional cases of FGM by 2030 due to the pandemic.more
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...ildren. If children with mild or no symptoms transmit the disease, they may act as drivers of transmission within their communities. Understanding symptoms, infectivity and patterns of SARS-CoV-2 transmission in children and adolescents is essential for developing, adapting and improving control measures for COVID-19 across all ages. This is a summary of the current knowledge around SARS-CoV-2 infection acquisition and transmission and COVID-19 disease symptoms in children and adolescents. It aims to inform decisions, based on local contexts, on how to best keep schools, kindergarten and day-care facilities open and what advice to apply to intergenerational mixing.more
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...ых средств для лечения COVID-19, в том числе гидроксихлорохина и комбинации лопинавира и
ритонавира . Размещение, распространение и обновление данных рекомендаций происходит в приложении
MAGICapp, а их формат и структура обеспечивают для пользователей удобство работы и поиска. Реализована
функция постоянного обновления информации, относящейся к действующим положениям, которая позволяет
знакомиться с новыми данными наряду с актуальными рекомендациями. В разделе 4 описаны основные
методологические аспекты процедуры составления вариативных рекомендаций.more
La presente publicación describe la literatura científica revisada sobre las intervenciones farmacológicas para el tratamiento de la enfermedad por el coronavirus 2019. El Ministerio de Salud solicitó la revisión de la evidencia disponible para nueve intervenciones terapéuticas frente a COVID-...19. Este listado contempla 03 intervenciones que no fueron consideradas en la Revisión Rápida de Intervenciones farmacológicas para el tratamiento de la enfermedad por el coronavirus 2019 . Serie Revisión Rápida N° 02-2020, correspondiendo a Ivermectina, Tocilizumab y pulsos de corticoides. En vista del rol potencial de cada intervención en el tratamiento de COVID-19, se plantearon dos respuestas PICO a fin de revisar la evidencia disponible respecto a siete potenciales opciones para tratamiento específico y dos fármacos que se han señalado como terapia adyuvante para frenar la respuesta inflamatoria presentada en COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19.more